Imperial College London

Dr Rufus Cartwright MD(res) MRCOG

Faculty of MedicineSchool of Public Health

Visiting Researcher







Institute of Reproductive and Developmental BiologyHammersmith Campus





MRC Clinical Research Training Fellow in urogynaecology focused on molecular and clinical genetics of pelvic floor disorders, novel  urinary biomarkers for overactive bladder syndrome, and non-invasive imaging techniques for obstetric perineal injury.



Miotla P, Cartwright R, Skorupska K, et al., 2017, Impact of intravesical onabotulinumtoxinA on sexual function in women with OAB, Neurourology and Urodynamics, Vol:36, ISSN:0733-2467, Pages:1564-1569

Aoki Y, Brown HW, Brubaker L, et al., 2017, Urinary incontinence in women, Nature Reviews Disease Primers, Vol:3, ISSN:2056-676X

Miotla P, Cartwright R, Skorupska K, et al., 2017, Urinary retention in female OAB after intravesical Botox injection: who is really at risk?, International Urogynecology Journal, Vol:28, ISSN:0937-3462, Pages:845-850

Bray R, Cartwright R, Cardozo L, et al., 2017, Tolterodine ER reduced increased bladder wall thickness in women with overactive bladder. A randomized, placebo-controlled, double-blind, parallel group study., Neurourol Urodyn

Lince SL, Kluivers KB, Cartwright R, et al., 2017, Exome chip study provides novel insights into the genetics of pelvic organ prolapse, European Journal of Obstetrics & Gynecology and Reproductive Biology, Vol:211, ISSN:0301-2115, Pages:207-207

More Publications